Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 11.86% is 108% above its 5-year average of -140.39%, near the high end of its 5-year range (-6456.48%–70.24%).
106.04% above its 12-month average of -196.23%.
Reported quarterly operating margin; no daily interpolation. Q3 FY2026 (2026-06-30): -226.03%.
OPERATING MARGIN
11.86%
OPERATING MARGIN AVG TTM
-196.23%
OPERATING MARGIN AVG 3Y
-202.99%
OPERATING MARGIN AVG 5Y
-140.39%
OPERATING MARGIN AVG 10Y
-147.51%
OPERATING MARGIN AVG 15Y
-4174.85%
OPERATING MARGIN AVG 20Y
-3747.58%
CURRENT VS TTM AVG
+106.04%
CURRENT VS 3Y AVG
+105.84%
CURRENT VS 5Y AVG
+108.45%
CURRENT VS 10Y AVG
+108.04%
CURRENT VS 15Y AVG
+100.28%
CURRENT VS 20Y AVG
+100.32%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 384 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Arrowhead Pharmaceuticals, Inc.
Market Cap
$8.78B
Operating Margin
11.86%
TTM Avg
-196.23%
3Y Avg
-202.99%
5Y Avg
-140.39%
Market Cap
$8.59B
Operating Margin
5.56%
TTM Avg
-28.40%
3Y Avg
-70.84%
5Y Avg
-47.21%
Market Cap
$9.11B
Operating Margin
-24.28%
TTM Avg
-49.63%
3Y Avg
-136.06%
5Y Avg
-90.71%
Market Cap
$8.41B
Operating Margin
4.07%
TTM Avg
-1.39%
3Y Avg
-5.39%
5Y Avg
-20.02%
Market Cap
$9.35B
Operating Margin
3.61%
TTM Avg
7.20%
3Y Avg
11.56%
5Y Avg
12.63%
Market Cap
$9.60B
Operating Margin
5.69%
TTM Avg
5.75%
3Y Avg
6.18%
5Y Avg
6.20%
Market Cap
$9.72B
Operating Margin
3.61%
TTM Avg
7.20%
3Y Avg
11.56%
5Y Avg
12.63%
Market Cap
$7.80B
Operating Margin
-695.44%
TTM Avg
-1799.08%
3Y Avg
-2632.66%
5Y Avg
-1827.24%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Arrowhead Pharmaceuticals, Inc. (ARWR) | $8.78B | 11.86% | -196.23% | -202.99% | -140.39% |
| Caris Life Sciences, Inc. (CAI)vs › | $8.59B | 5.56% | -28.40% | -70.84% | -47.21% |
| Axsome Therapeutics, Inc. (AXSM)vs › | $9.11B | -24.28% | -49.63% | -136.06% | -90.71% |
| Oscar Health, Inc. (OSCR)vs › | $8.41B | 4.07% | -1.39% | -5.39% | -20.02% |
| Bruker Corporation (BRKRP)vs › | $9.35B | 3.61% | 7.20% | 11.56% | 12.63% |
| Insulet Corp. (PODD)vs › | $9.39B | 16.89% | 16.20% | 12.06% | 10.90% |
| Henry Schein, Inc. (HSIC)vs › | $9.60B | 5.69% | 5.75% | 6.18% | 6.20% |
| Bruker Corporation (BRKR)vs › | $9.72B | 3.61% | 7.20% | 11.56% | 12.63% |
| Cytokinetics, Incorporated (CYTK)vs › | $7.80B | -695.44% | -1799.08% | -2632.66% | -1827.24% |
| Hinge Health, Inc. (HNGE)vs › | $7.61B | -92.94% | -50.55% | -48.57% | -48.57% |
Gross Margin
100.0%
Operating Margin
11.9%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -226.03% |
| 2026-03-31 | -191.57% |
| 2025-12-31 | 15.46% |
| 2025-09-30 | 17.20% |
| 2025-06-30 | -596.21% |
| 2025-03-31 | 70.24% |
| 2024-12-31 | -6456.48% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | -3845.25% |
| 2023-09-30 | -672.98% |
| 2023-06-30 | -648.99% |
| 2023-03-31 | 32.93% |
| 2022-12-31 | -67.36% |
| 2022-09-30 | -265.49% |
| 2022-06-30 | -224.94% |
| 2022-03-31 | 27.37% |
| 2021-12-31 | -230.77% |
| 2021-09-30 | -169.48% |
| 2021-06-30 | -69.44% |
| 2021-03-31 | -86.04% |
| 2020-12-31 | -112.91% |
| 2020-09-30 | -656.62% |
| 2020-06-30 | -58.25% |
| 2020-03-31 | -94.52% |
| 2019-12-31 | -16.48% |
| 2019-09-30 | 22.26% |
| 2019-06-30 | 43.55% |
| 2019-03-31 | 45.71% |
| 2018-12-31 | 31.58% |
| 2018-09-30 | -99.24% |
| 2018-06-30 | -2188.65% |
| 2018-03-31 | -2312.49% |
| 2017-12-31 | -393.56% |
| 2017-09-30 | -117.63% |
| 2017-06-30 | -61.16% |
| 2017-03-31 | -68.21% |
| 2016-12-31 | -341.36% |
| 2016-09-30 | -69744.37% |
| 2016-06-30 | -48863.12% |
| 2016-03-31 | -48605.38% |
| 2015-12-31 | -44208.62% |
| 2015-09-30 | -57668.19% |
| 2015-06-30 | -12924.21% |
| 2015-03-31 | -67731.98% |
| 2014-12-31 | -14708.80% |
| 2014-09-30 | -51095.56% |
| 2014-06-30 | -29028.80% |
| 2014-03-31 | -25628.57% |
| 2013-12-31 | -16021.44% |
| 2013-09-30 | -18283.66% |
| 2013-06-30 | -14605.41% |
| 2013-03-31 | -12320.66% |
| 2012-12-31 | -3024.87% |
| 2012-09-30 | -12293.66% |
| 2012-06-30 | -14197.33% |
| 2012-03-31 | -15580.02% |
| 2011-12-31 | -16858.83% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | -1126.42% |
| 2010-09-30 | -1299.58% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | -34.99% |
| 2009-12-31 | -1458.94% |
| 2009-09-30 | -1734.53% |
| 2009-06-30 | -87.53% |
| 2009-03-31 | -2204.24% |
| 2008-12-31 | -1222.18% |
| 2008-09-30 | 19330.06% |
| 2008-06-30 | -4204.66% |
| 2008-03-31 | -969.17% |
| 2007-12-31 | -1709.06% |
| 2007-09-30 | -2014.04% |
| 2007-06-30 | -2151.83% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | -40332.13% |
| 2006-09-30 | -22329.76% |
| 2006-06-30 | -1836.91% |
| 2006-03-31 | -10319.29% |
| 2005-12-31 | -1628.98% |
| 2005-09-30 | -980.15% |
| 2005-06-30 | -1618.57% |
| 2005-03-31 | -2148.36% |
| 2004-12-31 | -1295.63% |
| 2004-09-30 | -941.57% |
| 2004-06-30 | -1602.19% |
| 2004-03-31 | 0.00% |
| 2003-12-31 | 0.00% |
| 2003-09-30 | 0.00% |
| 2003-06-30 | -7295.17% |
| 2003-03-31 | -3367.89% |
| 2002-12-31 | -2056.34% |
| 2002-09-30 | -1482214.61% |
